Omega Diagnostics Group Plc (ODX) Receives Corporate Rating from FinnCap
FinnCap restated their corporate rating on shares of Omega Diagnostics Group Plc (LON:ODX) in a research report sent to investors on Tuesday. FinnCap currently has a GBX 28 ($0.35) price objective on the stock.
Omega Diagnostics Group Plc (LON:ODX) opened at 18.40 on Tuesday. The company’s 50-day moving average is GBX 17.37 and its 200-day moving average is GBX 17.23. Omega Diagnostics Group Plc has a 52 week low of GBX 13.50 and a 52 week high of GBX 21.00. The company’s market cap is GBX 20.01 million.
About Omega Diagnostics Group Plc
Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Receive News & Stock Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related stocks with our FREE daily email newsletter.